C-MER Medical Holdings Limited released its monthly return for the period ended 31 May 2026, confirming that its share capital structure and public float remained stable throughout the month.

Total authorised share capital stood unchanged at HKD 800.00 million, representing 8.00 billion ordinary shares with a par value of HKD 0.10 each.

Issued share capital also recorded no movement. The company closed May with 1.23 billion ordinary shares in issue, comprising 1.21 billion shares in public hands and 20.62 million shares held in treasury. No new shares were issued, cancelled or transferred during the month.

C-MER MEDICAL confirmed compliance with the Hong Kong Main Board’s minimum public-float requirement of 25%, as stipulated under Rule 13.32D(1).

Under its Post-IPO Share Option Scheme (exercise price: HKD 7.73), 133,334 options remained outstanding, identical to the prior month. The mandate still allows for up to 92.12 million shares to be issued upon future option exercises. No warrants, convertibles or other share-issuance arrangements were reported, and no treasury shares were transferred.

The monthly return was signed by Company Secretary Chan Wa Ping on 1 June 2026, affirming full compliance with all relevant listing and regulatory obligations.